Bridging solubility between drug discovery and development.
about
Development of micro-fibrous solid dispersions of poorly water-soluble drugs in sucrose using temperature-controlled centrifugal spinningMultifunctional polymeric micelles for delivery of drugs and siRNA.Interpreting physicochemical experimental data sets.Investigating the Dissolution Performance of Amorphous Solid Dispersions Using Magnetic Resonance Imaging and Proton NMR.Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-α/SPD304 StudyImproving both aqueous solubility and anti-cancer activity by assessing progressive lead optimization libraries.Novel tactics for designing water-soluble molecules in drug discovery.Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.Toward the establishment of standardized in vitro tests for lipid-based formulations. 5. Lipolysis of representative formulations by gastric lipase.Conductometric and volumetric studies of atorvastatin in aqueous solution of arginine from 298.15 to 313.15 KStereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.An uncharged oxetanyl sulfoxide as a covalent modifier for improving aqueous solubility.Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.Preliminary Evaluation of Artemisinin-Cholesterol Conjugates as Potential Drugs for the Treatment of Intractable Forms of Malaria and Tuberculosis.Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.Highly solvatochromic and tunable fluorophores based on a 4,5-quinolimide scaffold: novel CDK5 probes.Self-assembly induced solubilization of drug-like molecules in nanostructured ionic liquids.MetStabOn-Online Platform for Metabolic Stability Predictions.Tailoring supersaturation from amorphous solid dispersions.Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
P2860
Q27311607-1E4672F9-71FC-4F9B-A07D-DDAE68A87052Q30438973-2D1C4658-AE07-45C3-B5B7-A36C210901CDQ30967921-9CE3EB10-F1B0-4AF1-B104-13BABEA4AB85Q30993966-5160B8EB-CCD4-4001-ADDD-CCDD4B5283F6Q33635992-E2648132-7339-4B0C-B1EF-9C94D9CF9DB2Q35591252-1424A54E-1FA0-4666-8261-DE4E15D1CDC2Q38250126-069471A9-28FA-45CD-ACEC-1809F5B88964Q38729314-6E9A243B-55A4-4C32-9CC7-0A55C0CB0127Q38926514-CBBE9426-B128-4404-97BD-4A494EF5EDDFQ39117775-39413E8D-1236-491E-B11E-D7D722C556A0Q42052424-0C66F9F3-AE12-43B1-AF4B-79EF3CCCD49AQ42358786-88CC7485-A8D8-40D8-84AE-5C030DBA0099Q42808123-F952A3B4-ACD4-4071-8EC5-652648E180C8Q47624194-A5FD87C8-74CE-4193-B343-183FC9AD0E9DQ48018169-0F81AC8C-7C7A-4DE0-93DA-886C6541AD1FQ49687144-6443041A-CA78-4027-AE2C-57C1DDEFEF23Q50235954-1454ABA1-38A7-48C1-996C-879FAC94ECD7Q50955592-CAFDB3A2-15AA-442B-AB68-8D386E305A2EQ52337060-09FEC5CC-4EB6-4A6E-991D-31A56A9F4CA4Q53410930-7721DA3F-4868-44A2-91AF-90F1DAA3BE2DQ57492599-ABE347C1-2B60-4B3D-8B46-0B8510948575
P2860
Bridging solubility between drug discovery and development.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Bridging solubility between drug discovery and development.
@en
Bridging solubility between drug discovery and development.
@nl
type
label
Bridging solubility between drug discovery and development.
@en
Bridging solubility between drug discovery and development.
@nl
prefLabel
Bridging solubility between drug discovery and development.
@en
Bridging solubility between drug discovery and development.
@nl
P2093
P1433
P1476
Bridging solubility between drug discovery and development.
@en
P2093
P304
P356
10.1016/J.DRUDIS.2011.11.007
P577
2011-11-26T00:00:00Z